Presynaptic GABAA receptors control integration of nicotinic input onto dopaminergic axons in the striatum

Output Details

Axons of dopaminergic neurons express gamma-aminobutyric acid type-A receptors (GABAARs) and nicotinic acetylcholine receptors (nAChRs) which are both independently positioned to shape striatal dopamine release. Using electrophysiology and calcium imaging, we investigated how interactions between GABAARs and nAChRs influence dopaminergic axon excitability. Direct axonal recordings showed that benzodiazepine application suppresses subthreshold axonal input from cholinergic interneurons (CINs). In imaging experiments, we used the first temporal derivative of presynaptic calcium signals to distinguish between direct- and nAChR-evoked activity in dopaminergic axons. We found that GABAAR antagonism with gabazine selectively enhanced nAChR-evoked axonal signals. Acetylcholine release was unchanged in gabazine suggesting that GABAARs located on dopaminergic axons, but not CINs, mediated this enhancement. Unexpectedly, we found that a widely used GABAAR antagonist, picrotoxin, inhibits axonal nAChRs and should be used cautiously for striatal circuit analysis. Overall, we demonstrate that GABAARs on dopaminergic axons regulate integration of nicotinic input to shape presynaptic excitability.
Tags
  • Electrophysiology

Meet the Authors

  • User avatar fallback logo

    Sam Brill-Weil, BA

    Key Personnel: Team Edwards

    National Institute of Neurological Disorders and Stroke

  • Paul Kramer, PhD

    Key Personnel: Team Edwards

    National Institute of Neurological Disorders and Stroke

  • User avatar fallback logo

    Anthony Yanez, BA

    Key Personnel: Team Edwards

    National Institute of Neurological Disorders and Stroke

  • User avatar fallback logo

    Faye Clever, BSc

    Key Personnel: Team Edwards

    National Institute of Neurological Disorders and Stroke

  • User avatar fallback logo

    Renshu Zhang

  • Zayd Khaliq, PhD

    Co-PI (Core Leadership): Team Edwards

    National Institutes of Health

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.